Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 2/2019

Open Access 01-02-2019 | Original Contributions

Laparoscopic Adjustable Gastric Banding: an Underestimated Risk Factor for the Development of Esophageal Cancer?—a Nationwide Survey

Authors: Philipp Gehwolf, Katrin Kienzl-Wagner, Fergül Cakar-Beck, Aline Schäfer, Heinz Wykypiel

Published in: Obesity Surgery | Issue 2/2019

Login to get access

Abstract

Background

Approximately 14% of Austria’s 8.5 million inhabitants have a body mass index (BMI) > 30 kg/m2. The laparoscopic adjustable gastric banding (LAGB) was introduced in Austria in 1994, where about 10.300 patients have received it so far. One of our LAGB patients developed an adenocarcinoma of the distal esophagus 13 years after implantation.

Objectives

In order to calculate whether after LAGB patients are at higher risk for carcinoma of the esophagus, we performed a nationwide survey.

Methods

A questionnaire was sent to all surgical departments in Austria, primarily in order to detect cases with esophageal carcinoma after LAGB, but also to evaluate the policy in Austria concerning preoperative work-up, operation, and follow-up in LAGB patients.

Results

Since 1994, 37 of the 119 surgical departments in Austria have performed a total of about 10.300 LAGB implantations. Six patients have been identified with esophageal cancer following LAGB. The WHO statistical report on esophageal cancer shows an incidence of 2.8/100.000 per year in Austria, about 1/3 of which cases are adenocarcinoma of the distal esophagus.

Conclusion

Following LAGB, the incidence of esophageal cancer might be up to fivefold higher than the aged standardized overall population of Austria.
Literature
1.
Korswagen LA, Schrama JG, Bruins Slot W, et al. Adenocarcinoma of the lower esophagus after placement of a gastric band. Obes Surg. 2009;19(3):389–92.CrossRefPubMed
2.
Melstrom LG, Bentrem DJ, Salvino MJ, et al. Adenocarcinoma of the gastroesophageal junction after bariatric surgery. Am J Surg. 2008;196(1):135–8.CrossRefPubMed
3.
Kuruba R, Jawad M, Karl RC, et al. Technique of resection of esophageal adenocarcinoma after Roux-en-Y gastric bypass and literature review of esophagogastric tumors after bariatric procedures. Surg Obes Relat Dis. 2009;5(5):576–81.CrossRefPubMed
4.
Stauffer JA, Mathew J, Odell JA. Esophageal adenocarcinoma after laparoscopic gastric band placement for obesity. Dis Esophagus. 2011;24(1):E8–10.CrossRefPubMed
5.
Szewczyk T, Janczak P, Modzelewski B. Gastric cancer after laparoscopic adjustable gastric banding: case report. Wideochir Inne Tech Maloinwazyjne. 2012;7(3):210–2.PubMedPubMedCentral
6.
Scozzari G, Trapani R, Toppino M, et al. Esophagogastric cancer after bariatric surgery: systematic review of the literature. Surg Obes Relat Dis. 2013;9(1):133–42.CrossRefPubMed
7.
Wetscher GJ, Gadenstaetter M, Klingler PJ, et al. Efficacy of medical therapy and antireflux surgery to prevent Barrett’s metaplasia in patients with gastroesophageal reflux disease. Ann Surg. 2001;234(5):627–32.CrossRefPubMedPubMedCentral
8.
Wykypiel H, Kamolz T, Steiner P, et al. Austrian experiences with redo antireflux surgery. Surg Endosc. 2005;19(10):1315–9.CrossRefPubMed
9.
Gehwolf P, Bodner J, Augustin F, et al. Swedish adjustable gastric banding – an underestimated risk factor for the development of esophageal cancer? Eur Surg. 2011;43(6):387–9.CrossRef
10.
Gehwolf P, Hinder RA, DeVault KR, et al. Significant pressure differences between solid-state and water-perfused systems in lower esophageal sphincter measurement. Surg Endosc. 2015;29(12):3565–9.CrossRefPubMed
11.
Reavis KM. Management of the obese patient with gastroesophageal reflux disease. Thorac Surg Clin. 2011;21(4):489–98.CrossRefPubMed
12.
Weitzendorfer M, Köhler G, Antoniou SA, et al. Preoperative diagnosis of hiatal hernia: barium swallow X-ray, high-resolution manometry, or endoscopy? Eur Surg. 2017;49(5):210–7.CrossRefPubMedPubMedCentral
13.
Friedenberg FK, Xanthopoulos M, Foster GD, et al. The association between gastroesophageal reflux disease and obesity. Am J Gastroenterol. 2008;103(8):2111–22.CrossRefPubMed
14.
Nadaleto BF, Herbella FA, Patti MG. Gastroesophageal reflux disease in the obese: pathophysiology and treatment. Surgery. 2016;159(2):475–86.CrossRefPubMed
15.
Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143(3):199–211.CrossRefPubMed
16.
Lenglinger J, Izay B, Eisler M, et al. Barrett’s esophagus: size of the problem and diagnostic value of a novel histopathology classification. Eur Surg. 2009;41(1):26–39.CrossRef
17.
Koch OO, Antoniou SA. Advances in diagnosing GERD. Which examinations should be performed before interventional therapy? Eur Surg. 2016;48(4):203–8.
18.
Antoniou SA, Anastasiadou A, Antoniou GA, et al. Preoperative nutritional counseling versus standard care prior to bariatric surgery. Eur Surg. 2017;49(3):113–7.CrossRef
19.
20.
21.
22.
Casagrande DS, Rosa DD, Umpierre D, et al. Incidence of cancer following bariatric surgery: systematic review and meta-analysis. Obes Surg. 2014;24(9):1499–509.CrossRefPubMed
23.
Pescarus R, Sharata A, Shlomovitz E, et al. Endoscopic treatment for iatrogenic achalasia post-laparoscopic adjustable gastric banding. Surg Endosc. 2016;30(7):3099.CrossRefPubMed
24.
Wykypiel H. Pathophysiology of gastro-oesophageal reflux disease (GERD) with respect to reflux-induced carcinogenesis. Eur Surg. 2002;34:296–302.CrossRef
25.
Shaheen N, Ransohoff DF. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review. JAMA. 2002;287(15):1972–81.CrossRefPubMed
26.
Nason KS et al. Gastroesophageal reflux disease symptom severity, proton pump inhibitor use, and esophageal carcinogenesis. Arch Surg. 2011;146(7):851–8.CrossRefPubMedPubMedCentral
27.
Ardestani A, Tavakkoli A. Hiatal hernia repair and gastroesophageal reflux disease in gastric banding patients: analysis of a national database. Surg Obes Relat Dis. 2014;10(3):438–43.CrossRefPubMed
28.
Klaus A et al. Prevalent esophageal body motility disorders underlie aggravation of GERD symptoms in morbidly obese patients following adjustable gastric banding. Arch Surg. 2006;141(3):247–51.CrossRefPubMed
29.
Chen RY, Burton PR, Ooi GJ, et al. The physiology and pathophysiology of gastroesophageal reflux in patients with laparoscopic adjustable gastric band. Obes Surg. 2017;27(9):2434–43.CrossRefPubMed
30.
Genco A, Soricelli E, Casella G, et al. Gastroesophageal reflux disease and Barrett’s esophagus after laparoscopic sleeve gastrectomy: a possible, underestimated long-term complication. Surg Obes Relat Dis. 2017;13(4):568–74.CrossRefPubMed
31.
Melissas J, Braghetto I, Molina JC, et al. Gastroesophageal reflux disease and sleeve gastrectomy. Obes Surg. 2015;25(12):2430–5.CrossRefPubMed
32.
Mion F, Tolone S, Garros A, et al. High-resolution impedance manometry after sleeve gastrectomy: increased intragastric pressure and reflux are frequent events. Obes Surg. 2016;26(10):2449–56.CrossRefPubMed
33.
Melissas J, Daskalakis M, Koukouraki S, et al. Sleeve gastrectomy-a “food limiting” operation. Obes Surg. 2008;18(10):1251–6.CrossRefPubMed
34.
Scheepers AF, Schoon EJ, Nienhuijs SW. Esophageal carcinoma after sleeve gastrectomy. Surg Obes Relat Dis. 2011;7(4):e11–2.CrossRefPubMed
35.
Mackenzie H, Markar SR, Askari A, et al. Obesity surgery and risk of cancer. Br J Surg. 2018;105:1650–7.CrossRefPubMed
36.
37.
Renehan AG, Soerjomataram I. Obesity as an avoidable cause of cancer (attributable risks). Recent Results Cancer Res. 2016;208:243–56.CrossRefPubMed
38.
Parmar CD, Mahawar KK. One anastomosis (mini) gastric bypass is now an established bariatric procedure: a systematic review of 12,807 patients. Obes Surg. 2018;28:2956–67.CrossRefPubMed
39.
40.
41.
O’Brien PE et al. Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature. Ann Surg. 2013;257(1):87–94.CrossRefPubMed
Metadata
Title
Laparoscopic Adjustable Gastric Banding: an Underestimated Risk Factor for the Development of Esophageal Cancer?—a Nationwide Survey
Authors
Philipp Gehwolf
Katrin Kienzl-Wagner
Fergül Cakar-Beck
Aline Schäfer
Heinz Wykypiel
Publication date
01-02-2019
Publisher
Springer US
Published in
Obesity Surgery / Issue 2/2019
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-018-3576-2

Other articles of this Issue 2/2019

Obesity Surgery 2/2019 Go to the issue

Brief Communication

Psychological Support and Well-being in Post-Bariatric Surgery Patients

Other

Differences in Calcium Metabolism and Thyroid Physiology After Sleeve Gastrectomy and Roux-En-Y Gastric Bypass

Original Contributions

A Higher Preoperative Glycemic Profile Is Associated with Rapid Gastric Emptying After Sleeve Gastrectomy for Obese Subjects

Original Contributions

Short-Term Outcomes of Conversion of Failed Gastric Banding to Laparoscopic Sleeve Gastrectomy or Roux-En-Y Gastric Bypass: a Meta-Analysis

Original Contributions

Enhanced Recovery in Bariatric Surgery: A Study of Short-Term Outcomes and Compliance

Original Contributions

Longitudinal Comparison of the Effect of Gastric Bypass to Sleeve Gastrectomy on Liver Function in a Bariatric Cohort: Tehran Obesity Treatment Study (TOTS)